Search results
Morgan Stanley's Dividend Analysis
GuruFocus.com via Yahoo Finance· 2 days agoMorgan Stanley (NYSE:MS) recently announced a dividend of $0.85 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-29. As...
Morgan Stanley’s $20M bonuses draw proxy adviser’s fire
Banking Dive via Yahoo Finance· 19 hours agoGlass Lewis recommended shareholders reject a pay package that gave one-time $20 million awards to...
Morgan Stanley stock target raised by Oppenheimer By Investing.com
Investing.com· 16 hours agoOn Tuesday, Oppenheimer adjusted its price target for Morgan Stanley (NYSE: NYSE:MS), increasing it...
India's economy: The good, bad and ugly in six charts
BBC via Yahoo Finance· 2 hours agoIndia surpassed the UK as the fifth largest economy last year and according to analysts at Morgan ...
Here's How Much You Would Have Made Owning Morgan Stanley Stock In The Last 10 Years - Morgan ...
Benzinga· 11 hours agoMorgan Stanley MS has outperformed the market over the past 10 years by 1.53% on an annualized basis producing an average annual return of 11.92%. Currently ...
Morgan Stanley starts Dyne Therapeutics stock with Overweight, bullish on FORCE platform By...
Investing.com· 23 hours agoOn Tuesday, Morgan Stanley (NYSE:MS) began coverage on Dyne Therapeutics (NASDAQ:DYN) stock,...
Morgan Stanley’s Worst Mexico Scenario Has Peso Falling 11%
Bloomberg· 2 days agoHave a confidential tip for our reporters? The “super peso” could fall sharply if Mexico’s next...
Axsome Therapeutics (NASDAQ:AXSM) Stock Rating Upgraded by Morgan Stanley
ETF DAILY NEWS· 5 hours agoThe brokerage currently has a $115.00 price target on the stock, up from their prior price target of $90.00. Morgan Stanley’s price objective ...
Carlyle Picks JPMorgan, Morgan Stanley for IPO or Sale of StandardAero
Bloomberg via Yahoo Finance· 1 day agoIncreasingly, Only 10 MatterBinance and CZ’s Fortunes Are Set to Grow, Jail or no JailUS Warns ...
Contineum Therapeutics shares coverage initiated with $25 PT by Morgan Stanley By Investing.com
Investing.com· 21 hours agoTuesday, Morgan Stanley initiated coverage on Contineum Therapeutics (NASDAQ:CTNM), assigning an...